Jefferies trims UnitedHealth stock price target as Part D spending exceeds expectations By Investing.com
On Wednesday, Jefferies made an adjustment to the price target for UnitedHealth Group (NYSE:), lowering it slightly from $643.00 to $647.00, while still endorsing the stock with a Buy rating. The firm’s analysis suggests caution is warranted due to higher than anticipated spending in Part D, which was approximately 10% above their expectations.
The commentary from UnitedHealth’s third-quarter financial results indicated potential challenges for other insurance payers as well. The firm highlights that the guidance for 2025 from UnitedHealth suggests an earnings per share (EPS) increase of $2.25, which represents an 8% year-over-year growth. This projection is based on a starting point of $4.00, the midpoint of the Long Range Plan (LRP),…
